Creative Medical Technology Holdings, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $3.0K | $0 | $0 | $3.0K | $3.0K | $0 |
| Cost of Revenue | $0 | $0 | $994 | $0 | $0 | $1.2K | $1.2K | $0 |
| Gross Profit | $0 | $0 | $2.0K | $0 | $0 | $1.8K | $1.8K | $0 |
| Gross Margin | — | — | 66.9% | — | — | 60.0% | 60.0% | — |
| Operating Expenses | ||||||||
| Research & Development | $459.2K | $541.7K | $550.1K | $465.2K | $501.3K | $743.3K | $471.8K | $581.8K |
| SG&A Expense | $1.1M | $888.6K | $1.4M | $776.8K | $731.5K | $888.4K | $1.4M | $498.6K |
| Operating Income | $-1.6M | $-1.5M | $-1.9M | $-1.3M | $-1.3M | $-1.7M | $-1.9M | $-1.1M |
| Operating Margin | — | — | -64,859.4% | — | — | -55,349.3% | -62,857.8% | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-1.5M | $-1.4M | $-1.9M | $-1.2M | $-1.2M | $-1.6M | $-1.9M | $-1.0M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-1.5M | $-1.4M | $-1.9M | $-1.2M | $-1.2M | $-1.6M | $-1.9M | $-1.0M |
| Net Margin | — | — | -62,922.5% | — | — | -54,603.2% | -61,802.5% | — |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | $-0.41 | $-0.38 | $-0.73 | $-0.48 | $-0.48 | $-0.83 | $-2.58 | $-0.75 |
| Shares Outstanding (Basic) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Diluted) | 3.7M | 3.7M | 2.4M | 2.6M | 2.6M | 2.0M | 1.5M | 1.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |